Trials / Completed
CompletedNCT00850252
Use of a Lifeline Graft in the A-V Shunt Model
Use of a Completely Autologous and Completely Biological Tissue Engineered Blood Vessel Lifeline as an Arteriovenous Fistula in Hemodialysis Patients - Safety and Efficacy Study.
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Cytograft Tissue Engineering · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
This study will assess the safety and efficacy of a completely autologous and completely biological tissue engineered blood vessel (TEBV) called Lifeline™ used as an arteriovenous fistula for dialysis access.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Lifeline | Surgical arteriovenous fistula formation with the use of Lifeline blood vessel |
Timeline
- Start date
- 2004-09-01
- Primary completion
- 2012-01-01
- Completion
- 2012-12-01
- First posted
- 2009-02-24
- Last updated
- 2013-07-17
Locations
2 sites across 2 countries: Argentina, Poland
Source: ClinicalTrials.gov record NCT00850252. Inclusion in this directory is not an endorsement.